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Introduction 
The human gut microbiota makes critical contributions to host 
health (Fukuda et al., 2011; Round and Mazmanian, 2009). How-
ever, it has also become increasingly clear that several systemic 
diseases are associated with aberrations in gut microbiota com-
position often referred to as ‘‘dysbiosis’’ (Walker and Lawley, 
2013). Although few cause-and-effect relationships have been 
established in humans, strong associations between gut micro-
biota composition and various pathologies provide a compel-
ling case for the development of strategies that target the gut 
microbiota and, ideally, reverse dysbiotic patterns (Olle, 2013). 
One of the strategies used to modulate the gut microbiota 
is by dietary administration of live microorganisms, often re-
ferred to as probiotics (Hill et al., 2014) or live biotherapeutics 
(Olle, 2013). There is substantial literature published on the use 
of lactic acid bacteria in human clinical trials, many of which re-
ported beneficial effects (Ceapa et al., 2013). However, the de-
gree to which clinical improvements have been causally linked 
to probiotic- induced microbiota changes has not been estab-
lished (Sanders et al., 2013). Moreover, most strains show high 
survival rates in the gastrointestinal tract, but are subsequently 
detectable for less than 2 weeks following cessation of intake 
(Alander et al., 2001; Charbonneau et al., 2013; Firmesse et al., 
2008; Frese et al., 2012; Malinen et al., 2002; Rattanaprasert et al., 
2014; Rochet et al., 2008). In most studies, the introduction of a 
live microbe did not result in significant alterations of the fecal 
microbiota (Kristensen et al., 2016). Overall, the persistence and 
ecological impacts of introducing live microbes in the human 
gut appear limited, and fundamental questions remain regarding 
the feasibility of establishing live microbes in the human gut and 
the modulatation of the microbiome through such an approach. 
The gastrointestinal tract and its microbiota constitute an in-
teractive ecosystem in which spatial, temporal, and functional 
characteristics are governed by the principles of community 
ecology (Walter and Ley, 2011). The introduction of a microor-
ganism into the gut ecosystem can be considered as a biolog-
ical invasion of a non-native organism into a resident micro-
bial community (Costello et al., 2012). Invasion ecology provides 
a framework to study and understand the incursion of a for-
eign species into an established community (Shea and Ches-
son, 2002). Several questions addressed in the field directly 
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Abstract 
Live bacteria (such as probiotics) have long been used to modulate gut microbiota and human physiology, but their col-
onization is mostly transient. Conceptual understanding of the ecological principles as they apply to exogenously intro-
duced microbes in gut ecosystems is lacking. We find that, when orally administered to humans, Bifidobacterium longum 
AH1206 stably persists in the gut of 30% of individuals for at least 6 months without causing gastrointestinal symptoms 
or impacting the composition of the resident gut microbiota. AH1206 engraftment was associated with low abundance 
of resident B. longum and underrepresentation of specific carbohydrate utilization genes in the pre-treatment microbi-
ome. Thus, phylogenetic limiting and resource availability are two factors that control the niche opportunity for AH1206 
colonization. These findings suggest that bacterial species and functional genes absent in the gut microbiome of indi-
vidual humans can be reestablished, providing opportunities for precise and personalized microbiome reconstitution. 
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apply to the application of probiotics and live biotherapeutics. 
Which traits make a species a successful invader or colonizer? 
What features of an ecosystem determine their susceptibility 
to invasions? What is the ecological impact? Although invasion 
ecology currently lacks a unifying theory that addresses these 
questions (Guo et al., 2015), it provides a useful framework for 
understanding probiotic functionality and impact and ultimately 
may advance their application. For example, according to theory, 
specific traits that overcome the environmental filters of the eco-
system are required for biological invasions (Mächler and Alter-
matt, 2012; Olyarnik et al., 2009). The inability of commercial pro-
biotic strains to persist in the human gut might therefore stem 
from the absence of key adaptations necessary to successfully 
compete in this ecosystem. This might be because most probi-
otic strains currently used belong to bacterial taxa (e.g., Lacto-
bacillus species, Bifidobacterium animalis subsp. lactis, etc.) that 
are allochthonous to the human gastrointestinal tract (Biavati 
and Mattarelli, 2012; Walter, 2008). There is clearly a knowledge 
gap regarding how dominant autochthonous members of the 
gut microbiota would perform ecologically, both in terms of per-
sistence as well as their impact on the resident microbiota, after 
being introduced into the human gut. 
The goal of this study was to systematically assess the eco-
logical role and impact of a bacterial species autochthonous to 
the human intestinal tract when administered to human indi-
viduals, applying a framework based on invasion ecology the-
ory. We selected a strain of Bifidobacterium longum, a bacterial 
species known to be a core member of the human gastrointes-
tinal microbiota that forms stable and numerically dominant 
populations in most individuals (Martínez et al., 2013; Schloiss-
nig et al., 2013; Turroni et al., 2009). We conducted a double-
blinded, crossover, placebo-controlled trial in healthy humans 
aimed at (1) assessing how long a highly adapted bacterium 
can be established in the human gastrointestinal tract, (2) de-
termining the impact of this administration on the resident 
bacterial community, (3) determining the effect of this strain 
on gastrointestinal symptoms of the subjects, and (4) identi-
fying the precise community features of the resident microbi-
ome that determine colonization. 
Results 
Introduction of B. longum AH1206 into the Digestive Tract 
of Humans 
We performed a human crossover trial in which 23 subjects con-
sumed a daily dose of 1010 viable cells of B. longum subsp. 
longum AH1206 or a placebo (maltodextrin) in random succes-
sion, with 38 or 46 days washout between treatments (Figure 
1A). Fecal samples were collected at baseline, days 7 and 14 of 
the treatment period, and 4, 8, 15, and 28 days after comple-
tion of each treatment for ‘‘test of persistence’’ (TOP). From fresh 
fecal samples, total bifidobacteria were quantitatively cultured, 
and 30 randomly picked colonies per subject at baseline and 14 
days of treatment were typed by strain-specific PCR. As shown in 
Figure 1B, this analysis revealed that the test strain was detect-
able at around 7.4 ± 1.2 log10 viable cells/gram of feces during 
AH1206 treatment period, but not during the baseline or pla-
cebo periods (samples that showed a carry-over effect were ex-
cluded), indicating survival of AH1206 during transit through the 
gastrointestinal tract. No adverse effects were detected during 
consumption of AH1206 as determined by a standardized ques-
tionnaire for gastrointestinal symptoms (Figure S1). 
B. longum AH1206 Colonizes the Gut of a Subset of Indi-
viduals for Extended Periods of Time 
Three independent approaches were used to test for AH1206 
persistence. Quantification in fecal samples via strain-specific 
quantitative real-time PCR (qPCR) revealed that the strain was 
undetectable (<104 cells per gram) prior to treatment in all but 
one subject (this subject was therefore removed from further 
analysis). The strain became detectable in all subjects during 
the treatment period and reached an average population of 
7.7 ± 0.9 and 7.6 ± 0.8 log10 cells/gram of feces after 1 and 2 
weeks of administration, respectively (Figure 1C). The average 
levels of AH1206 decreased after cessation of consumption, but 
remained significantly elevated 28 days after treatment com-
pared to the pre-treatment baseline (p < 0.05) (Figure 1C). In 
addition, AH1206 remained detectable in three subjects dur-
ing the baseline and placebo phases of the second test pe-
riod, suggesting the strain could persist in a subset of subjects 
beyond 28 days after being consumed. To test for long-term 
persistence of AH1206, we collected fecal samples at 11 and 
20 weeks after completion of the trial. This analysis revealed 
that AH1206 abundance was still significantly elevated in the 
20 week follow-up samples compared to pre-treatment base-
line levels (Figure 1C). When assessing AH1206 levels among all 
subjects in an individual basis, it became clear that there was a 
substantial degree of inter-personal variability in the levels of 
persistence (Figure 1D). In 14 subjects (64%), the strain became 
undetectable between day 4 and 28 of washout. However, in 
eight subjects (36%) the strain remained present at levels be-
tween 106 and 1010 (average 7.43 ± 1.33 log10) cells per gram 
of feces >88 days and in seven subjects (27%) for >166 days 
after consumption cessation. 
To determine persistence of AH1206 using an approach not re-
liant on the detection of a single marker gene, we sequenced 
the genome of B. longum AH1206 and identified genes of this 
strain that were absent in the combined pre-treatment (base-
line) microbiomes of all participants. This was done by mapping 
metagenomic reads against the AH1206 genome and consider-
ing only matches with 100% homology. This analysis identified 
26 genes specific to AH1206. We then determined the abun-
dance of these genes in samples collected pre-treatment, after 
14 days of probiotic consumption, and around 200 days after 
consumption by mapping the metagenomics sequence reads 
against the AH1206-specific genes. Most of the genes became 
detectable during treatment (p < 0.0001 for all subjects) and re-
mained significantly higher for persisters after treatment cessa-
tion (p = 0.0313 for all subjects baseline versus ~200 days TOP), 
while they disappeared in most non-persisters (p = 0.2500 base-
line versus ~200 days TOP) (Figure 2A). These results demon-
strate that a set of genes unique to AH1206 remained detect-
able in persisters for around 200 days after consumption of the 
strain, confirming long-term persistence. 
To determine if AH1206 could be recovered after prolonged 
colonization periods, we selectively cultured bifidobacteria from 
fecal samples of persisters collected after 20 weeks and typed 30 
random colonies per subject by strain-specific PCR. Isolates that 
typed as AH1206 were recovered from four subjects. Of those, 
five random isolates per individual were then typed by multilocus 
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sequence analysis (MLSA). This analysis showed that all isolates 
belonged to the species B. longum, and for three subjects, the 
isolates displayed the same sequence type as AH1206 (i.e., the 
sequences of all seven housekeeping genes were identical) (Ta-
ble S1). These findings demonstrated that, despite the difficulty 
to detect a particular strain by culture among the resident culti-
vable Bifidobacterium population of around 109 cells per gram, 
AH1206 could be recovered from three individuals around 200 
days after being administered. 
Overall, the results clearly demonstrate that AH1206 can col-
onize the human gut in high numbers for prolonged periods of 
time in a subset of individuals. We refer to this subset of indi-
viduals as ‘‘persisters’’, while those who did not permit coloni-
zation are named ‘‘non-persisters’’. Persistence was at least 166 
days for seven subjects, but in one subject, (J), AH1206 became 
undetectable in the first follow-up sample, which coincided with 
the use of a prescribed laxative product containing antimicrobial 
components. Since this subject completed the entire crossover 
trial and showed persistence of AH1206 for 88 days, which was 
substantially longer than persistence in non-persisters (max. 28 
days; Figure 1D), this subject was considered a persister. It was 
therefore included for analyses that compared microbiome at 
baseline and during treatments, but excluded from the analyses 
of the microbiome of the 20 week follow-up sample. 
Administration of AH1206 Does Not Alter the Taxonomic 
Composition of the Fecal Microbiota 
Illumina sequencing of 16S rRNA gene tags (V5–V6 region) re-
vealed that administration of AH1206 did not change the struc-
ture of the overall bacterial communities of the fecal microbiota 
(Adonis permutational multivariate ANOVA [PERMANOVA], p = 
0.999) and proportions of specific members, including Bifido-
bacterium species (Figures S2A–S2E). In addition, a-diversity was 
not altered by either treatment (data not shown). Compositional 
analysis by whole-metagenome sequencing (WMS) confirmed 
the lack of impact of AH1206 on the taxonomical composition of 
the fecal microbiota (Figure S2A). However, the functional analy-
sis revealed a significant increase of 29 genes during consump-
tion of AH1206 (Figure 2B; Table S2). Remarkably, all these genes 
were assigned to the species B. longum and have more than 98% 
Figure 1. Experimental Design and Survival and Persistence of B. longum Subsp. longum AH1206 in the Human Gut 
(A) Experimental design of the human trial. The arrows indicate the collection of fecal samples, completion of Gastrointestinal Symptom Rating Scale 
(GSRS) forms, and samples that were sequenced and used for typing of isolates. 
(B) Proportions of strain AH1206 among the total cultured bifidobacteria during the two baseline periods, treatment, and placebo as determined by 
colony PCR with strain-specific primers. The groups labeled with different letters are significantly different (repeated-measures two-way ANOVA; 
a = 0.05, p < 0.0001). 
(C) Quantification of B. longum AH1206 in fecal samples by strain-specific qPCR. The data are represented as mean and SE. Baseline: BL. The signifi-
cant difference between time points and baseline are indicated by asterisks. Repeated-measures two-way ANOVA with Dunnett’s multiple com-
parison; ***p < 0.001; **p % 0.01; and *p % 0.05. 
(D) Cell numbers of B. longum AH1206 in fecal samples determined by qPCR throughout the entire trial with subjects categorized as persisters (closed 
symbols) and non-persisters (open symbols).  
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DNA identity to AH1206 genes (100% coverage). Therefore, al-
though administration of AH1206 did not alter the taxonomic 
composition of the fecal microbiota, it enriched for functional 
genes belonging to the species B. longum. 
Ecological Characteristics of the Resident Gut Microbiota 
Are Not Major Determinants of Long-Term Persistence 
Comparison of overall community configurations in persisters 
and non-persisters at baseline using b-diversity values (Bray- 
Curtis distances), NMDS plots, and Adonis PERMANOVA re-
vealed no differences (p = 0.2488) (Figure 3A). Higher diver-
sity has been associated with a lower invasion susceptibility of 
a community, as higher species richness is likely to translate di-
rectly into higher diversity of functional traits, elevated resource 
depletion, as well as an increased probability of competitive spe-
cies to be present (Díaz and Cabido, 2001; Kennedy et al., 2002; 
Mallon et al., 2015; Tilman, 2004). However, although trends were 
observed, neither total a-diversity (p = 0.0759 for total opera-
tional taxonomic units [OTUs] and p = 0.2901 for Shannon diver-
sity index) (Figure 3B) nor functional richness (p = 0.0759 and p 
= 0.0818, for single and assembled reads, respectively, data not 
shown) were significantly higher in non-persisters. Evenness has 
also been described as a barrier to invasions (De Roy et al., 2013; 
Wittebolle et al., 2009), but no differences were detected (p = 
0.1423) (Figure 3C). In addition, disturbances have been shown 
to facilitate invasion of non-native species (Elton, 1958; Kneitel 
and Perrault, 2007). However, although higher stability was as-
sociated with resistance to short-term colonization of food-born 
microbes in a rat model (Zhang et al., 2016), long-term coloni-
zation of AH1206 in humans was not linked to fecal microbiota 
stability (p = 0.6087 for Morisita-Horn) (Figure 3D). 
Community Membership Differs in Persisters and 
Non-persisters 
To determine possible competitive interactions of AH1206 with 
specific members of the gut microbiota, we compared the com-
position of fecal bacterial communities at baseline (i.e., pre-treat-
ment) to identify and rank taxa that discriminate persisters from 
non-persisters using both Wilcoxon tests and random forest (RF) 
analysis (Figure 3E). Results revealed that Coriobacteriaceae fam-
ily (p = 0.0243, mean importance 2.5), Collinsella genus (p = 
0.0169, mean importance 2.57), and Collinsella aerofaciens (OTU 
1, p = 0.0357, mean importance 1.52) were reduced in persisters. 
In contrast, Eggerthella (p = 0.0229, mean importance 3.30) and 
Eggerthella lenta (OTU 52, p = 0.0497,mean importance 1.96) 
were elevated in persisters (Figure S3B; Table S3). The most dis-
criminative taxon, however, was the OTU that represented B. 
longumOTU11,whichshowed a higher abundance in non-per-
sisters (Wilcoxon test, p = 0.0022; random forest mean impor-
tance 6.12) (Figures 3A and S3C). Consistent findings were ob-
tained with minimum entropy decomposition (MED) (p = 0.004) 
and species-specific qPCR (p = 0.0367) (Figure S3C). 
Figure 2. WMS Analysis Confirms Establishment and Persistence of AH1206 
(A) Quantification of genes unique to B. longum AH1206 in fecal samples taken during pre-treatment baseline, consumption of the strain (14 days), 
and around 200 days after consumption. Mean coverage for each AH1206-specific gene was obtained by mapping metagenomics sequence 
reads against AH1206 specific genes absent in the combined pre-treatment metagenome. The bars represent the relative abundance (y axis) of 
each of the 26 genes (x axis). 
(B) Administration of AH1206 caused enrichment of a set of genes belonging to the species B. longum into the gut ecosystem. The relative abun-
dances (mean coverage) before and during consumption are shown.  
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The significantly higher proportions of fecal B. longum at 
baseline in non-persisters suggest that colonization of AH1206 
might be prevented by other strains within the same species. 
Ecology theory predicts that competition would be stronger be-
tween phylogenetically related organisms as they share simi-
lar traits and therefore display a larger degree of niche overlap. 
Accordingly, colonization would be prevented by competitive 
exclusion (Hardin, 1960), a process collectively referred to as 
phylogenetic limiting (Violle et al., 2011). To test for phyloge-
netic limiting, we quantified the proportion of 16S rRNA-gene 
tag sequences from fecal samples obtained during pre-treat-
ment baseline and the placebo periods that matched strain 
AH1206 with decreasing levels of sequence similarity. This anal-
ysis revealed significantly higher proportions in non-persisters 
at higher percent similarity (>97%), while at lower sequence sim-
ilarities (93%–95%) differences became non-significant (Figure 
S3D), suggesting that AH1206 colonization is prevented through 
phylogenetic limiting. 
The Microbiome of Persisters and Non-persisters Differs in 
the Abundance of B. longum Genes 
The findings described above indicated that baseline B. longum 
abundance is inversely associated with persistence. However, 
B. longum levels did not explain the findings in all subjects, in 
Figure 3. Influence of Ecological Factors on AH1206 Invasibility of Baseline Fecal Microbial Communities (A) Overall comparison of community pro-
files between persisters and non-persisters revealed no significant differences (p = 0.2488; Adonis PERMANOVA). The data are shown by NMDS. 
(B–D) a-diversity (B), evenness (C), and stability (D) of the fecal microbiota of persisters and non-persisters. Data in boxplots show the median, 
first, and third quartiles (hinges); whiskers are extended to the highest value within the 1.5 3 IQR of the upper and lower hinges. (E and F) Bar-
plots of the average abundance ratio of highly discriminant taxonomic groups (E) and B. longum genes (F) in pre-treatment samples in persist-
ers and non-persisters. OTUs for which percentages of identity are not indicated have >99% identity to the type strain of the indicated bacterial 
species. Mean importance and p values were determined by random forest analysis and Mann-Whitney-Wilcoxon test, respectively. Persister: P, 
Non-Persister: NP.   
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that some persisters had relatively high levels of B. longum. Be-
cause traits that define niches and competitive interactions are 
not necessarily phylogenetically conserved in bacteria, and can 
differ substantially within the same bacterial species (Zhu et 
al., 2015), we used WMS data and compared the abundance of 
genes identified to belong to the species B. longum, at pretreat-
ment baseline between persisters and non-persisters. A Wilcoxon 
test resulted in 70 genes with differential abundance between 
persisters and non-persisters (Figure 3F; Table S4). These genes 
comprised functions involved in metabolism, cellular processes, 
and information storage and processing, with genes involved in 
carbohydrate metabolism accounting for many of these func-
tions (38% of the genes with assigned functions). Even though 
multiple correction test (FDR) rejected all genes identified as sig-
nificant, 93% of the discriminative genes and 100% of the genes 
involved in carbohydrate metabolism were enriched in non-per-
sisters, suggesting a clear pattern in the discriminant features. 
Given the limited ability of classical hypothesis testing meth-
ods in identifying significant features from highly complex and 
noisy data sets like microbiomes (Knights et al., 2011), we inde-
pendently identified genes that discriminated persisters from 
non-persisters using a random forest classifier. This analysis re-
vealed that a total of 60 (90%) of the previously identified genes 
had good discriminative power (mean importanceR0.01) (Table 
S4). The 13 genes that best discriminate (mean importance > 1) 
between persisters and non-persisters are shown in Figure 3F. 
Consistent with the findings above, more than half of the genes 
were involved in carbohydrate metabolism and all but one were 
overrepresented in non-persisters. 
To determine which taxonomic and gene-based microbiome 
signatures are the best predictors of B. longum AH1206 coloni-
zation, all predictive features, taxonomic groups (Table S3), and 
functional genes (Table S4) were ranked by random forest clas-
sifier based on AH1206 persistence. This analysis showed that, 
overall, B. longum genes were better predictors of AH1206 per-
sistence than bacterial taxa (Table S5). However, OTU 11 ranked 
second, showing that this taxon has a strong predictive value. 
To test specifically if genes are better predictors of invasion than 
OTU 11 proportions, we compared independent linear models 
regressing persistence against the OTU and a gene, respectively, 
to a combined linear model, using ANOVA. This analysis revealed 
that genes, 1830 (permeases of the major facilitator superfamily) 
and 0877 (b-galactosidase ranked sixth), outperform B. longum 
levels at predicting persistence of AH1206 (p < 0.0005 and p < 
0.001 for 1830 and 0877, respectively). 
Genes that Predict Colonization Show Inter-individual 
Variation among the Resident B. longum Populations 
The analyses above showed that although B. longum abundance 
was identified as a significant predictor of invasibility, several B. 
longum genes scored higher. In addition, the subject with the 
highest population of B. longum (around 17% of total bacterial 
sequences at baseline pre-treatment) was a persister (subject 
D), while several non-persisters harbored low proportions of B. 
longum (Figure 4A). To determine whether this discrepancy could 
be explained by inter-personal variation in gene abundance, we 
selected six discriminant genes that were predicted to have a 
key role in carbohydrate utilization and quantified their abun-
dance by qPCR. This analysis revealed that at baseline, non-per-
sisters that had relative low levels of resident B. longum still har-
bored, for the most part, comparable levels of these genes as 
did non-persisters with higher levels of B. longum (Figure 4A). 
In contrast, four of the discriminant genes were not detectable 
in the outlier persister with high levels of native B. longum (sub-
ject D). This analysis suggests interindividual variability of genes 
among the resident B. longum population, consistent with re-
cent findings in several dominant species present in the human 
gut (Zhu et al., 2015). 
To address this variability from a genomic perspective, we an-
alyzed gene coverage within the genomic regions (obtained after 
metagenome assembly) that included the discriminative genes 
in individual participants. Gene coverage of the entire gene-con-
taining contigs revealed higher and consistent coverage for non-
persisters, reflecting the higher average levels of B. longum (Fig-
ure 4B). In contrast, the discriminative genes were absent in most 
persisters, even those that showed a high degree of coverage in 
the flanking regions (e.g., subject D). Overall, these findings in-
dicate that genes that predict persistence are not phylogeneti-
cally conserved, as they were present in non-persisters with low 
B. longum abundance and absent in most persisters with high B. 
longum levels, with only one single exception (subject B). 
Genes Predictive of Colonization Encode Functional Traits 
that Constitute a Niche for AH1206 
The underrepresentation of carbohydrate-utilization genes in 
persisters might result in the availability of resources that con-
stitute a vacant niche for AH1206. For this to apply, two condi-
tions would have to be met. First, strain AH1206 would have to 
possess the functional traits encoded by these genes to success-
fully occupy the niche, and second, the differences in the rela-
tive abundance of these genes in persisters and non-persisters 
should disappear after the establishment of AH1206 as a con-
sequence of the strain occupying the niche. 
To determine if both conditions apply, we first determined if 
the genes that were shown to discriminate persisters from non-
persisters (Table S4) were present in AH1206. A total of 65 out 
of the 70 discriminate genes (93%) had homologs (amino-acid 
similarity >98%, 100% coverage) in the genome of AH1206, sug-
gesting that this strain indeed possesses most of the traits nec-
essary to occupy the vacant niche. Second, to test if the niche 
becomes occupied after AH1206 is established, we conducted an 
NMDS analysis using the mean coverage (based on WMS data) 
of the 70 discriminative genes of persisters and non-persisters 
at baseline. This analysis revealed that while baseline samples 
Figure 4. Abundance of Representative Discriminatory Genes in Individual Subjects (A) Absolute abundance of representative genes that predict col-
onization as quantified by qPCR of persisters with high levels and non-persisters with low levels of B. longum. The average and SE of the abso-
lute abundance of genes in all subjects is also shown. (B) Relative abundance represented as the mean coverage of the WMS reads within rep-
resentative genomic regions containing genes that predict persistence. The shaded areas display the genes of interest.  
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of persisters and non-persisters clustered separately (Figure 5A) 
(Adonis PERMANOVA, p = 0.005), the clustering disappeared 
during AH1206 consumption (Figure 5B) and ~200 days after 
consumption (Figure 5C) (Adonis PERMANOVA, p = 0.2736 and 
p = 0.3383), respectively. In addition, individual carbohydrate-
utilization genes showed significant differences in abundance 
at baseline, yet these differences disappeared during establish-
ment and persistence of AH1206 (Figures 5D–5I). We confirmed 
quantification of the six genes with key roles in carbohydrate uti-
lization by qPCR. This analysis revealed that the significant dif-
ferences in abundance of five out of the six genes detected at 
baseline between persisters and non-persisters disappeared af-
ter AH1206 was established (Figure S4). Overall, these findings 
support the hypothesis that the genes that are underrepresented 
in persisters encode traits that reflect an open niche, allowing 
AH1206 to stably colonize.  
Figure 5. Differences in Gene Distribution in Persisters and Non-persisters Disappear after Engraftment of B. longum AH1206 NMDS plots based on 
Bray-Curtis distance calculated with the abundance of 70 genes that differ in persisters and non-persisters. Baseline (A), probiotic treatment (B), 
and around 200 days TOP (C). Boxplots showing average gene abundance for genes g 2015, Lacl-type response repressor (D); g 1077, Lacl-fam-
ily transcriptional regulator (E); g 1467, (F), and g 1830, permeases of the major facilitator superfamily (COG0477) (G); g 1136, ABC-type sugar 
transport system permease component (H); and g 0877, b-galactosidase (I). Means and SEM are shown. Wilcoxon test; **p % 0.01; *p % 0.05; 
and not significant: n.s.    
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Discussion
 In this study, we applied a conceptual framework based on in-
vasion ecology to reveal insights into how an autochthonous 
member of the human gut microbiota colonizes the human 
gastrointestinal tract, the ecological characteristics of the res-
ident microbiome that influence colonization, and the implica-
tions that arise from colonization for both the microbiome and 
the host. By using a combination of complementary methods, 
we demonstrated stable persistence of B. longum AH1206 in a 
subset of subjects dependent on individualized features of the 
resident gut microbiome likely related to variations in the ex-
istence of an open niche. One central focus of invasion ecol-
ogy is the determination of the ecological impact that invasive 
species have on an ecosystem (Simberloff et al., 2013). This is 
relevant for the application of probiotics and live biotherapeu-
tics as their effect on the resident microbiota could range from 
beneficial to detrimental. Our study clearly established that ad-
ministration of AH1206 neither resulted in changes to the resi-
dent microbiome nor detectable adverse effects (gastrointestinal 
symptoms) for the human hosts. Based on these findings, and in 
accordance to proposed invasion ecology nomenclature (Davis 
and Thompson, 2000), we argue that the long-term establish-
ment of AH1206 qualifies this organism as a colonizer and not 
as an invader. Here, we propose the term ‘‘engraftment’’, which 
refers in general terms to an ‘‘incorporation in a firm or perma-
nent way’’ (Dictionaries, 2014), and in medical terms, to an ‘‘in-
corporation of grafted tissue into the body of the host’’ (Miller 
et al., 2005), as the term to refer to the stable establishment of 
a bacterial strain in the human gut. 
The findings of long-term persistence of AH1206 contrast 
with those from a vast majority of studies with live microbes that 
show limited persistence. Interestingly, the only other study to 
our knowledge that established long-term persistence of an in-
gested strain in a subset of participants using a strictly strain-
specific approach also utilized a strain of B. longum (Fujiwara et 
al., 2001). Together, these findings suggest that autochthonous 
core members of the human gut microbiome may display el-
evated levels of persistence when compared to allochthonous 
species currently used in commercial probiotic products. How-
ever, it remains unclear whether the ability of stable engraftment 
is a more general attribute of autochthonous gut microbes or 
rather is a particular attribute of specific strains of B. longum. 
Next-generation probiotics and live biotherapeutics based on 
core members of the gut microbiome (e.g., those that are under-
represented in dysbioses) are currently being developed (Olle, 
2013). The findings obtained in this study are therefore directly 
relevant for the development of microbiometargeted strategies 
as they suggest that an autochthonous bacterial strain may have 
a higher ecological fitness when administered to humans than 
allochthonous strains. Although it is not yet known if ecologi-
cal performance relates to increased probiotic functionality, the 
findings warrant future research on the health effects on autoch-
thonous gut microbes. 
This study identified a strong and statistically significant 
phylogenetic signal associated with colonization of AH1206, 
showing that establishment was prevented, likely through com-
petitive exclusion, in the presence of phylogenetically related 
organisms within the resident microbiome. Therefore, our find-
ings support Darwin’s naturalization hypothesis that states that 
introduced species are more successful at surviving in commu-
nities in which their close relatives are absent (Darwin, 1859). 
In contrast, Li et al. (2016) showed that bacterial strains intro-
duced through fecal transplants are more likely to be estab-
lished in the recipient human if the species are already pres-
ent. Similarly, Stecher et al. (2010) suggested a ‘‘like will to like’’ 
rule in that colonization of both pathogens and commensals 
in the murine gut is favored by the presence of related spe-
cies. Inconsistencies regarding the role of phylogenetic relat-
edness in colonization success have been observed in other 
ecosystems and have been attributed to the notion that phy-
logenetic patterns of community assembly are often scale de-
pendent and confounded by extrinsic factors such as fluctu-
ations in environmental conditions (Li et al., 2015; Proches et 
al., 2008; Thuiller et al., 2010). In this respect, it is important to 
recognize that environmental filtering (selection for phyloge-
netically related members that share traits that enable coloni-
zation) and competitive exclusion (selection for phylogeneti-
cally distinct members with different traits that result in niche 
differences) act together in ecosystems (Mayfield and Levine, 
2010). The processes that determine which species co-exist and 
assemble within gut microbial ecosystems are therefore likely 
to be context, scale, and taxon dependent. 
Although our findings indicate competitive exclusion of 
AH1206 by the resident B. longum population, exceptions ex-
isted where either persisters harbored high populations of B. 
longum or non-persisters had low levels of it. In this respect, it 
has to be noted that functional traits (including those that de-
fine niches) are not necessarily evolutionarily conserved in bac-
teria (Shafquat et al., 2014). This can directly influence the degree 
by which phylogenetic relatedness conveys competitive interac-
tions among members of the human gut microbiome. Most bac-
terial species, including B. longum, possess pan-genomes with 
individual strains displaying variation in genomic content (Chap-
lin et al., 2015; O’Callaghan et al., 2015). Horizontal gene trans-
fer can further lead to similar genetic information being shared 
among bacterial taxa that are not closely related, resulting in 
phylogenetically distant taxa with similar traits (Boto, 2010). Our 
trait-based analysis demonstrated that specific functional genes 
of the species B. longum are better predictors of engraftment 
when compared to B. longum itself. It appears that the niche of 
AH1206 is occupied by B. longum in most non-persisters, al-
though exceptions exist in which it is either not occupied by B. 
longum in persisters (through interspecies genetic variability) or 
is occupied by other taxa in nonpersisters (through HGT). There 
was only one exception in our study that did not concur with 
this explanation (subject B), a persister harboring both high lev-
els of B. longum and discriminative genes (Figure 4). We specu-
late that persistence in this individual might have been caused 
by AH1206 being able to compete with the resident strain(s), 
which is supported by a metagenomics analysis of single nucle-
otide variations that suggests that AH1206 co-exists with native 
members of B. longum (data not shown). 
The majority of the genes that discriminated the pre-treat-
ment microbiome of non-persisters from persisters were under-
represented in persisters and involved in carbohydrate utiliza-
tion. This finding suggested that the establishment of AH1206 
was dependent on resource availability, or accordingly, a niche 
opportunity (Shea and Chesson, 2002). Some of the genes en-
code for b-galactosidases and LacI-type regulatory proteins, 
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indicating that galactose-containing substrates, which have been 
shown to contribute to the nutritional niche of bifidobacteria in 
the human gut (Davis et al., 2011; O’Connell et al., 2013), con-
tribute to the colonization success of AH1206. Accordingly, ho-
mologs of the discriminative genes g0877 and g2015 are present 
in gene clusters of AH1206 that are highly conserved in Bifido-
bacterium breve (Figure S5). These particular regions have been 
functionally characterized in B. breve to be involved in the utili-
zation of the plant-derived carbohydrates galactan and melezi-
tose, respectively (O’Connell Motherway et al., 2011; O’Connell 
et al., 2014). It is therefore possible that the variation of dietary 
habits (not assessed during this study) might have contributed 
to the individual differences in AH1206 colonization. Overall, the 
findings support the theoretical framework proposed by Mallon 
et al. (2015), which postulates that resistance of microbial com-
munities to invasion is linked to resource depletion. However, en-
graftment of AH1206 appears to be less dependent on species 
richness and evenness and more on the presence of commu-
nity members that are functionally similar to AH1206. Our find-
ings are in complete agreement with mechanistic studies in mice 
showing that colonization of Bacteroides strains was prevented 
only by members of the same species and driven by competition 
for specific carbohydrates (Lee et al., 2013). Deletion of a poly-
saccharide utilization locus in Bacteroides fragilis reduced com-
petitive exclusion and allowed colonization of a second strain. 
These findings provide an explanation for why the persisters with 
high baseline B. longum levels in our study may still allow en-
graftment of AH1206 if the resident strains lack specific carbo-
hydrate-utilization genes. 
Overall, the findings of this study suggest that specific core 
members of the gut microbiome and functional genes asso-
ciated with them can be established in humans in which they 
are absent. This important discovery could provide a basis for 
precision microbiome reconstitution to redress specific dysbi-
otic patterns. In addition, this study provides an early demon-
stration for how engraftment of a bacterial strain can be pre-
dicted based on microbiome features. Such predictions could 
be applied to personalize the use of probiotics and live bio-
therapeutics to increase their beneficial value. More extensive 
human studies with autochthonous bacterial strains are war-
ranted to establish their health benefits, develop and validate 
reliable predictive models, and test the potential to personalize 
such approaches based on these models. Moreover, the abil-
ity of a probiotic strain to persist when specific niche-defining 
resources are available reinforces the potential of the symbi-
otic concept (Kolida and Gibson, 2011). If systematically devel-
oped based on ecological criteria (Krumbeck et al., 2015), syn-
biotics could ensure the provision of growth substrates (in the 
form of dietary carbohydrates or prebiotics) that enable long-
term persistence of probiotic strains. 
Experimental Procedures 
The human trial was approved by the Institutional Review Board of the 
University of Nebraska (IRB Approval Number: 222-12-FB) and registered 
in Clinical Trials web page (Identifier: NCT01650753). Written informed 
consent was obtained from all subjects. 
Experimental Design 
A double-blind, placebo-controlled, human crossover study with two 
7-week test periods (including a baseline, a 14-day treatment, and a 
28-day TOP) in 24 healthy human subjects (22 and 38 years of age) was 
conducted with the primary objective to determine acceptability and 
safety of B. longum subsp. longum AH1206 at a daily dose of 1010 cells 
(Figure 1A). In total, 16 fecal samples were collected from every subject 
for selective culture of bifidobacteria (for strain typing of bacterial iso-
lates) and DNA isolation (for sequencing and qPCR). To evaluate toler-
ance of AH1206 intake, subjects provided weekly reports of gastroin-
testinal symptoms as described previously (Rattanaprasert et al., 2014). 
Detailed information about the experimental design, bacterial culture 
and strain typing, and DNA isolation is provided in the Supplemental 
Experimental Procedures. 
Quantification of Strain AH1206 and the Species B. longum by qPCR 
B. longum AH1206 was quantified in fecal DNA by qPCR using a strain-
specific primers and probe system (probe #89; Roche, Universal Pro-
beLibrary). Bifidobacterium longum was quantified by qPCR with spe-
cies-specific primers. Details about the PCR program, primers, and 
validation of the PCR system can be found in the Supplemental Exper-
imental Procedures. 
Sequencing of 16S rRNA Gene Tags and WMS 
The fecal microbiota in samples collected during the baseline (of AH1206 
treatment period), the last day of AH1206 consumption, the last day of 
placebo consumption, and 28 days of TOP was characterized by next-
generation sequencing as described by Krumbeck et al. (2015). WMS was 
performed with fecal samples obtained during baseline, the last day of 
consumption of the probiotic, and the 20 week follow-up sample using 
the Illumina HiSeq 2500 platform. The accession number for the raw se-
quences reported in this paper is NCBI SRA: PRJNA324129. The software 
Anvi’o (Eren et al., 2015) was used to generate, visualize, and quantify 
genomic bins in the metagenomic data set. See Supplemental Experi-
mental Procedures for details on sequencing and a description of the 
bioinformatics analysis. 
Ecosystem Characteristics 
Measurements of a- and b-diversity as well as community evenness were 
calculated using QIIME tools v 1.8.0 (Caporaso et al., 2011). b-diversity 
measurements were used to assess temporal stability of an individual’s 
fecal microbiota as the average of the distance between all consecutive 
time points. Bray-Curtis distances between samples were calculated and 
visualized in by non-metric multidimensional scaling (NMDS). See Sup-
plemental Experimental Procedures for details. 
Absolute Quantification of Functional Genes by qPCR 
To confirm findings obtained with the metagenomics analysis, qPCR sys-
tems were developed for representative genes discriminant between per-
sisters and non-persisters (see Supplemental Experimental Procedures). 
Statistical Methods 
Repeated-measures two-way ANOVAs with Bonferroni correction, re-
peated measures one-way ANOVAs, and Friedman tests were used to 
determine the effect of treatment on microbiota taxonomic and func-
tional composition and diversity measurements. Mann-Whitney-Wil-
coxon tests were used to conduct pairwise comparisons between time 
points and compare bacterial and gene abundances, a-diversity, stabil-
ity, evenness, and functional richness between persisters and non-per-
sisters. Permutational multivariate ANOVA (Adonis PERMANOVA with 
200 permutations) based on sample distances (b-diversity) was used to 
test for changes in the community composition. In order to identify dis-
criminative independent variables, generate predictive models, and com-
pare their performance, and compare the importance of variables that 
predict the persistence of AH1206, random-forest analysis and ANOVA 
tests were used. See the Supplemental Experimental Procedures for de-
tailed descriptions of the statistical methods. 
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Accession Numbers 
The accession number for the raw 16S rRNA, metagenomics, and MLST 
reported in this paper is NCBI SRA: PRJNA324129.   
Supplemental Information Supplemental Information includes Sup-
plemental Experimental Procedures, five figures, and five tables and 
can be found with this article online at http:// dx.doi.org/10.1016/j.
chom.2016.09.001. 
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